MJBizDaily lists its most clicked-on cannabis stories of 2023, including those about a dangerous viroid, delta-8 THC and rescheduling.
Roger Fillion
Roger Fillion's Latest Posts
Fresh lawsuit targets New York’s rollout of adult-use marijuana
New York regulators are facing yet another lawsuit aimed at stopping them from issuing any additional adult-use marijuana licenses.
Kate Lavin to succeed Roger Fillion as MJBizDaily editorial director
After a long career in journalism and almost eight years with MJBizDaily, Roger Fillion will retire as editorial director and will be succeeded by the publishing platform’s magazine editor Kate Lavin, MJBiz announced Wednesday.
Judge backs steep fee hike for Florida medical marijuana operators
An administrative judge in Florida gave the thumbs-up to a new rule adopted a year ago by state regulators that boosted the biennial license renewal fee for medical marijuana companies in the state by more than twentyfold, to $1.3 million.
Cannabis MSO Jushi files CA$600 million shelf prospectus
Cannabis multistate operator Jushi Holdings filed a preliminary short-form base shelf prospectus in Canada to raise up to 600 million Canadian dollars ($442 million) by issuing a variety of securities over a 25-month period.
Pamela Moore stepping down from top content position at MJBiz
Pamela Moore, the chief content strategy officer for MJBiz, is leaving the pioneering cannabis publishing and trade show company after four years.
Marijuana operator Tilt Holdings ends ties with social equity brands
Tilt Holdings, a Phoenix-based diversified marijuana company, has cut ties with three social equity brands and paused a joint venture with the Shinnecock Indian Nation in New York.
Cannabis irradiation poses quandary for growers, scares consumers
Cannabis cultivators are caught up in a dilemma about providing clean and safe product that has passed inspection for acceptable levels of microbial contaminants.
How to capitalize on consumer data to personalize marijuana marketing
Marijuana companies can offer a more personalized cannabis experience for consumers by digging deeper into data about customer preferences.
Researchers combine cannabis and psilocybin for medical treatments
Combining cannabinoids with psilocybin into a single formula for treating both physical and mental health issues took another step closer to reality as described in a product patent from a major cannabinoid laboratory, CaaMTech.
Marijuana advertisers face hurdles with Twitter’s newest ad policies
Twitter might have further eased its rules for cannabis advertising, but the changes don’t seem to have made it any easier for marijuana businesses to take advantage of the social media platform’s wide reach.
CT seeks THC caps on unregulated marijuana products, synthetics ban
Connecticut legislators took the first step toward outlawing synthetic marijuana and imposing THC caps on sleep aids and other consumable products sold in convenience and CBD stores outside the state’s regulated medical and recreational cannabis markets.
